RECRUITINGN/A

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Sponsor

University of Pittsburgh

Enrollment

200 participants

Sites

1 locations

Start Date

October 2004

Completion

January 2030

Cutaneous T-cell LymphomaSezary SyndromeMycosis FungoidesEczemaAtopic Dermatitis

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

200

participants

Sites

locations

Duration

27.3 years

total trial span

Rate

pts/month needed

Oct 2004Month 263 of 327Jan 2030

80% of trial timeline elapsed64 months to primary endpoint

At 1 sites, each site needs to enroll approximately 1.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Proteomics of Cutaneous T-cell lymphoma

Ongoing

Proteomic variables will be measured in blood and tissue of consented CTCL patients.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

RECRUITINGN/A

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Sponsor

University of Pittsburgh

Enrollment

200 participants

Sites

1 locations

Start Date

October 2004

Completion

January 2030

Cutaneous T-cell LymphomaSezary SyndromeMycosis FungoidesEczemaAtopic Dermatitis

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

200

participants

Sites

locations

Duration

27.3 years

total trial span

Rate

pts/month needed

Oct 2004Month 263 of 327Jan 2030

80% of trial timeline elapsed64 months to primary endpoint

At 1 sites, each site needs to enroll approximately 1.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Proteomics of Cutaneous T-cell lymphoma

Ongoing

Proteomic variables will be measured in blood and tissue of consented CTCL patients.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

18 Years

Sex

all

Healthy Volunteers

View full criteria

Inclusion Criteria:

* 18 or older
* able and willing to provide informed consent
* diagnosed with CTCL
* diagnosed with either atopic dermatitis or eczema

Exclusion Criteria:

* Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)